U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
COMMISSION FILE NUMBER 001-09974
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-K & Form-10 KSB [X] Form 11-K [ ] Form 20-F
[ ] Form 10-Q & Form 10-QSB [ ] Form N-SAR
For the Period Ended: December 31, 2003
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
PART I- REGISTRANT INFORMATION
Full Name of Registrant: Enzo Biochem, Inc.
------------------
Former Name if Applicable:
--------------------------------
Address of Principal Executive Office (Street and Number):60 Executive Boulevard
----------------------
City, State and Zip Code: Farmingdale, New York 11735
---------------------------
PART II - RULE 12b-25(b)AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check appropriate box.)
[X] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
[X] (b) The subject annual report, semi-annual report, transition report
on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof
will be filed on or before the 15th calendar day following the
prescribed due date; or the subject quarterly report or transition
report on Form 10-Q, or portion thereof will be filed on or before
the fifth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K and Form 10-KSB,
11-K, 20-F, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion
thereof could not be filed within the prescribed time period.
THE COMPANY'S FORM 11-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2003
CANNOT BE FILED WITHIN THE PRESCRIBED TIME PERIOD BECAUSE THE FINANCIAL
INFORMATION FOR THE YEAR ENDED DECEMBER 31, 2003 COULD NOT BE COMPLETED
BY THE AUDITORS BY THE REQUIRED FILING DUE DATE. THE FORM 11-K WILL BE
FILED AS SOON AS PRACTICABLE.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Robert H. Cohen, (212) 801-6907
-------------------------------
(Name)(Area Code)(Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the
preceding 12 months or for such shorter period that the registrant was
required to file such report(s) been filed? If the answer is no, identify
report(s):
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or
portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
ENZO BIOCHEM, INC.
------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: June 28, 2004 By: /s/ Barry W. Weiner
-----------------------------------------
Barry W. Weiner
Chief Financial Officer